Bowel (colorectal) cancer, Colon cancer, Rectal cancer, Secondary cancers
Results
Phase 2
This trial looked at a drug called imgatuzumab for people with bowel cancer that had spread to other parts of the body (advanced bowel cancer).
Recruitment start: 29 April 2011
Recruitment end: 22 June 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Cunningham
Experimental Cancer Medicine Centre (ECMC)
F. Hoffmann - La Roche
Limited
Last reviewed: 21 February 2019
CRUK internal database number: 7660